Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Marital status after colorectal surgery in familial adenomatous polyposis: a nationwide multicenter study in Japan

    Patients with familial adenomatous polyposis (FAP) experience psychological and social challenges concerning future events such as marriage and childbirth alongside the medical risks of colorectal cancer (CRC)...

    Kenji Fujiyoshi, Tomoya Sudo, Fumihiko Fujita in International Journal of Clinical Oncology (2024)

  2. No Access

    Article

    Clinical features and distribution of the APC variant in duodenal and ampullary polyps in patients with familial adenomatous polyposis: a multicenter retrospective cohort study in Japan

    Management of duodenal or ampullary adenomas in patients with familial adenomatous polyposis (FAP) is a major challenge for clinicians. Insufficient data are available to evaluate the clinical manifestations a...

    Yasuyuki Miyakura, Tatsuro Yamaguchi in International Journal of Clinical Oncology (2024)

  3. No Access

    Article

    Risk of metachronous colorectal cancer after colectomy for first colon cancer in Lynch syndrome: multicenter retrospective study in Japan

    We evaluated the risk of metachronous colorectal cancer (mCRC) and explored the optimal extent of colectomy in patients with Lynch syndrome (LS) and first colon cancer (fCC) in Japan, where the extent of colec...

    Kenichi Chikatani, Hideyuki Ishida in International Journal of Clinical Oncology (2023)

  4. Article

    Open Access

    The effect of specimen processing time on HER2 expression in gastric cancer and esophagogastric junction cancer: a single-center retrospective observational study

    Recent developments in the field of companion diagnosis and molecular-targeting therapeutic agents have helped in develo** treatments targeting human epidermal growth factor receptor 2 (HER2) in gastric canc...

    Yoshitomo Yanagimoto, Hiroshi Imamura, Shiro Adachi, Kazuki Odagiri in BMC Cancer (2023)

  5. Article

    Correction to: Risk of first onset of colorectal cancer associated with alcohol consumption in Lynch syndrome: a multicenter cohort study

    Kenji Fujiyoshi, Tomoya Sudo, Fumihiko Fujita in International Journal of Clinical Oncology (2022)

  6. No Access

    Article

    Risk of first onset of colorectal cancer associated with alcohol consumption in Lynch syndrome: a multicenter cohort study

    Complex interactions among endogenous and exogenous factors influence the incidence of colorectal cancer (CRC). Germline mutations in mismatch repair (MMR) genes causing Lynch syndrome (LS) are major endogenou...

    Kenji Fujiyoshi, Tomoya Sudo, Fumihiko Fujita in International Journal of Clinical Oncology (2022)

  7. Article

    Correction to: APC germline variant analysis in the adenomatous polyposis phenotype in Japanese patients

    Misato Takao, Tatsuro Yamaguchi in International Journal of Clinical Oncology (2022)

  8. Article

    Open Access

    Evaluation of a 55-gene classifier as a prognostic biomarker for adjuvant chemotherapy in stage III colon cancer patients

    Adjuvant chemotherapy reduces the risk of recurrence of stage III colon cancer (CC). However, more effective prognostic and predictive biomarkers are needed for better treatment stratification of affected pati...

    Eiji Oki, Eiji Shinto, Mototsugu Shimokawa, Shigeki Yamaguchi in BMC Cancer (2021)

  9. No Access

    Article

    APC germline variant analysis in the adenomatous polyposis phenotype in Japanese patients

    Familial adenomatous polyposis (FAP), an autosomal dominant disorder characterized by multiple colonic polyps, is caused by a germline pathogenic variant of the APC gene. However, this variant is not detected in ...

    Misato Takao, Tatsuro Yamaguchi in International Journal of Clinical Oncology (2021)

  10. Article

    Open Access

    Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer

    Hereditary colorectal cancer (HCRC) accounts for < 5% of all colorectal cancer cases. Some of the unique characteristics commonly encountered in HCRC cases include early age of onset, synchronous/metachronous ...

    Naohiro Tomita, Hideyuki Ishida in International Journal of Clinical Oncology (2021)

  11. No Access

    Article

    Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study)

    Chemotherapy in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy is under debate. REACT study aimed to investigate the efficacy of reintroducing modified FOLFOX6 (mFOLFOX6)...

    Masahito Kotaka, Shigeyoshi Iwamoto in International Journal of Clinical Oncology (2020)

  12. No Access

    Article

    Phase II study of S-1-based sequential combination chemotherapy including oxaliplatin plus bevacizumab and irinotecan with or without cetuximab for metastatic colorectal cancer: the SOBIC trial

    Fluorouracil and leucovorin combined with oxaliplatin or irinotecan plus bevacizumab (Bmab) or cetuximab (Cmab) are now widely accepted treatment options as first-line or second-line chemotherapy for metastati...

    Yoshihiko Nakamoto, Masafumi Noda in International Journal of Clinical Oncology (2020)

  13. No Access

    Article

    Introduction: Lynch syndrome—its molecular mechanism and current topics

    Naohiro Tomita in International Journal of Clinical Oncology (2019)

  14. Article

    Erratum to: Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer

    Takeshi Suto, Megumi Ishiguro, Chikuma Hamada in International Journal of Clinical Oncology (2017)

  15. Article

    Open Access

    Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer

    Six months of adjuvant chemotherapy is regarded as the standard of care for patients with stage III colon cancer. However, whether longer treatment can improve prognosis has not been fully investigated. We con...

    Takeshi Suto, Megumi Ishiguro, Chikuma Hamada in International Journal of Clinical Oncology (2017)

  16. No Access

    Article

    Feasibility of laparoscopic total proctocolectomy with ileal pouch–anal anastomosis and total colectomy with ileorectal anastomosis for familial adenomatous polyposis: results of a nationwide multicenter study

    Data supporting the safety and feasibility of laparoscopic total proctocolectomy with ileal pouch–anal anastomosis (TPC-IPAA) and total colectomy with ileorectal anastomosis (TC-IRA) for patients with familial...

    Tsuyoshi Konishi, Hideyuki Ishida in International Journal of Clinical Oncology (2016)

  17. No Access

    Article

    Prevalence of laparoscopic surgical treatment and its clinical outcomes in patients with familial adenomatous polyposis in Japan

    Laparoscopic surgery is becoming the preferred technique for most colorectal interventions. This study aimed to clarify the time trend of surgical treatment for familial adenomatous polyposis (FAP) and its rel...

    Hideki Ueno, Hirotoshi Kobayashi in International Journal of Clinical Oncology (2016)

  18. Article

    Open Access

    Prognostic significance of classified extramural tumor deposits and extracapsular lymph node invasion in T3–4 colorectal cancer: a retrospective single-center study

    Extramural tumor deposits (TDs) and extracapsular lymph node involvement (ECLNI) are considered to be poor prognostic factors in patients with T3–4, N0–2, M0 colorectal cancer (CRC). Although TDs are known to ...

    Tomoki Yamano, Shuho Semba, Masafumi Noda, Mie Yoshimura, Masayoshi Kobayashi in BMC Cancer (2015)

  19. No Access

    Article

    Preventive effect of Gosha**kigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study

    Peripheral sensory neurotoxicity is a frequent adverse effect of oxaliplatin therapy. Calcium and magnesium (Ca/Mg) infusions are frequently used as preventatives, but a recent phase III trial failed to show t...

    Eiji Oki, Yasunori Emi, Hiroshi Kojima in International Journal of Clinical Oncology (2015)

  20. Article

    Open Access

    New molecular staging with G-factor supplements TNM classification in gastric cancer: a multicenter collaborative research by the Japan Society for Gastroenterological Carcinogenesis G-Project committee

    The G-Project committee was erected by the Japan Society for Gastroenterological Carcinogenesis with an aim of establishing a new classification scheme based on molecular biological characteristics that would ...

    Tetsuji Sawada, Masakazu Yashiro, Kazuhiro Sentani, Naohide Oue in Gastric Cancer (2015)

previous disabled Page of 2